These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2844304

  • 1. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G, Martin JM, Luis J, el Battari A, Muller JM, Marvaldi J, Pichon J.
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [Abstract] [Full Text] [Related]

  • 2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 3. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
    Muller JM, Luis J, Fantini J, Abadie B, Giannellini F, Marvaldi J, Pichon J.
    Eur J Biochem; 1985 Sep 02; 151(2):411-7. PubMed ID: 2992966
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL, O'Dorisio MS, Vassalo LM, Malarkey WB, O'Dorisio TM.
    Regul Pept; 1985 Nov 07; 12(3):237-48. PubMed ID: 3001842
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.
    Wood CL, O'Dorisio MS.
    J Biol Chem; 1985 Jan 25; 260(2):1243-7. PubMed ID: 2981838
    [Abstract] [Full Text] [Related]

  • 11. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A, Marie JC.
    Endocrinology; 1987 Mar 25; 120(3):978-85. PubMed ID: 3026793
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 25; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 13. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A, Martin JM, Luis J, Pouzol O, Secchi J, Marvaldi J, Pichon J.
    J Biol Chem; 1988 Nov 25; 263(33):17685-9. PubMed ID: 2846575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J, Martin JM, Luis J, Rémy L, Tirard A, Marvaldi J, Pichon J.
    Eur J Cell Biol; 1988 Aug 25; 46(3):458-65. PubMed ID: 2846304
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S, Kopras E, McMichael M, Bell RH, Ulrich CD.
    Cancer Res; 1997 Apr 15; 57(8):1475-80. PubMed ID: 9108448
    [Abstract] [Full Text] [Related]

  • 19. VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.
    Rouyer-Fessard C, Augeron C, Grasset E, Maoret JJ, Laboisse CL, Laburthe M.
    Experientia; 1989 Dec 01; 45(11-12):1102-5. PubMed ID: 2557231
    [Abstract] [Full Text] [Related]

  • 20. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
    Laburthe M, Rousset M, Rouyer-Fessard C, Couvineau A, Chantret I, Chevalier G, Zweibaum A.
    J Biol Chem; 1987 Jul 25; 262(21):10180-4. PubMed ID: 3038870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.